What are the potential interactions between Acamprosate (Campral) and Mesalamine (Mesalazine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There are no significant known interactions between Campral (acamprosate) and mesalazine (also known as mesalamine or 5-ASA), and these medications can generally be taken together safely. Campral is used to maintain alcohol abstinence by normalizing brain neurotransmitter systems disrupted by chronic alcohol use, while mesalazine is an anti-inflammatory medication primarily used to treat inflammatory bowel diseases like ulcerative colitis and Crohn's disease. The medications work through different mechanisms and target different body systems - Campral primarily affects the central nervous system, while mesalazine works locally in the intestines with minimal systemic absorption. However, as with any medication combination, it's essential to inform your healthcare provider about all medications you're taking. Both medications can occasionally cause digestive side effects like diarrhea or nausea, so monitoring for increased gastrointestinal symptoms would be prudent. Kidney function should also be monitored as Campral is eliminated through the kidneys, and dosage adjustments may be needed in patients with renal impairment 1.

Some key points to consider when taking these medications together include:

  • Monitoring for increased gastrointestinal symptoms such as diarrhea or nausea
  • Regular kidney function tests to ensure safe elimination of Campral
  • Informing your healthcare provider about all medications you're taking to minimize potential interactions
  • Being aware of the different mechanisms and target body systems of each medication to understand potential side effects and interactions.

It's also important to note that while there are no significant known interactions between Campral and mesalazine, it's always best to consult with a healthcare professional before starting or stopping any medication regimen. They can provide personalized guidance and help you weigh the benefits and risks of taking these medications together 1.

In terms of the medications themselves, mesalazine is often used to treat mild to moderate ulcerative colitis, and can be effective in inducing and maintaining remission 1. Campral, on the other hand, is used to maintain alcohol abstinence and can be an effective tool in the treatment of alcohol dependence 1.

Overall, while there are no significant known interactions between Campral and mesalazine, it's crucial to be aware of the potential side effects and interactions of each medication and to consult with a healthcare professional before starting or stopping any medication regimen.

From the Research

Potential Interactions between Acamprosate and Mesalamine

There are no research papers to assist in answering this question, as the provided studies do not mention Acamprosate (Campral) or its potential interactions with Mesalamine (Mesalazine) 2, 3, 4, 5, 6.

Mesalamine Side Effects and Interactions

  • Mesalamine can cause nephrotoxicity, including interstitial nephritis, in rare cases 3, 4.
  • The risk of nephrotoxicity is not clearly dose-related, but rather idiosyncratic 3.
  • Mesalamine can also cause gastrointestinal side effects, such as diarrhea and abdominal pain 5, 6.
  • Patients with a history of sulphasalazine or sulphonamide intolerance or allergy should be treated with caution when using mesalamine 5.

Mesalamine Mechanism of Action and Efficacy

  • The exact mechanism of action of mesalamine in the treatment of inflammatory bowel disease is unknown 6.
  • Mesalamine has been shown to be effective in treating active ulcerative colitis, proctitis, and proctosigmoiditis, as well as maintaining remission in patients with ulcerative colitis 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.